Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-15

Clinical Trial Update: Efficacy and Safety of GRT6005 in Patients With Chronic Low Back Pain. [Phase 2]

View source ↗

Summary

Phase 2 trial update on the efficacy and safety of GRT6005 in chronic low back pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GRT6005

Snippet

Sponsor: Tris Pharma, Inc. | Conditions: Low Back Pain | Phase 2 | Status: COMPLETED